Heparin-induced thrombocytopenia: diagnosis and management

Circulation. 2004 Nov 2;110(18):e454-8. doi: 10.1161/01.CIR.0000147537.72829.1B.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anticoagulants / adverse effects*
  • Anticoagulants / immunology
  • Anticoagulants / therapeutic use
  • Aortic Valve Insufficiency / surgery
  • Arginine / analogs & derivatives
  • Autoantibodies / immunology
  • Autoimmune Diseases / chemically induced*
  • Autoimmune Diseases / diagnosis
  • Autoimmune Diseases / immunology
  • Autoimmune Diseases / therapy
  • Female
  • Fingers / blood supply
  • Heart Valve Prosthesis Implantation
  • Heparin / adverse effects*
  • Heparin / immunology
  • Heparin / therapeutic use
  • Hirudins / immunology
  • Humans
  • Ischemia / etiology
  • Ischemia / pathology
  • Middle Aged
  • Necrosis
  • Pipecolic Acids / immunology
  • Pipecolic Acids / therapeutic use
  • Platelet Activation / immunology
  • Platelet Factor 4 / immunology
  • Postoperative Complications / prevention & control
  • Raynaud Disease / complications
  • Recombinant Proteins / immunology
  • Recombinant Proteins / therapeutic use
  • Sulfonamides
  • Thrombocytopenia / chemically induced*
  • Thrombocytopenia / diagnosis
  • Thrombocytopenia / immunology
  • Thrombocytopenia / therapy
  • Thrombosis / prevention & control
  • Toes / blood supply
  • Warfarin / adverse effects
  • Warfarin / therapeutic use

Substances

  • Anticoagulants
  • Autoantibodies
  • Hirudins
  • Pipecolic Acids
  • Recombinant Proteins
  • Sulfonamides
  • Platelet Factor 4
  • Warfarin
  • Heparin
  • Arginine
  • argatroban
  • lepirudin